SAN DIEGO — During 2019 and 2020, patients with pulmonary arterial hypertension lost around 8% of available workdays, according to research presented at the American Thoracic Society International Conference.“PAH clinicians know the significant impact PAH has on patients’ lives,” Anna Watzker, MHS, associate director of outcomes research at Merck, told Healio. “This